Colchicine poisoning: the dark side of an ancient drug
Y Finkelstein, SE Aks, JR Hutson, DN Juurlink… - Clinical …, 2010 - Taylor & Francis
Introduction. Colchicine is used mainly for the treatment and prevention of gout and for
familial Mediterranean fever (FMF). It has a narrow therapeutic index, with no clear-cut …
familial Mediterranean fever (FMF). It has a narrow therapeutic index, with no clear-cut …
The management of gout
BT Emmerson - New England Journal of Medicine, 1996 - Mass Medical Soc
Gout is a clinical syndrome resulting from the deposition of urate (monosodium urate
monohydrate) crystals. The crystals may be deposited in a joint, leading to an acute …
monohydrate) crystals. The crystals may be deposited in a joint, leading to an acute …
Colchicine: 1998 update
E Ben-Chetrit, M Levy - Seminars in arthritis and rheumatism, 1998 - Elsevier
OBJECTIVE:: To present an update of the use of colchicine in patients with familial
Mediterranean fever (FMF) and other rheumatic and nonrheumatic diseases. DATA …
Mediterranean fever (FMF) and other rheumatic and nonrheumatic diseases. DATA …
Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement
T Kallinich, D Haffner, T Niehues, K Huss, E Lainka… - …, 2007 - publications.aap.org
The daily application of colchicine is the standard therapy for prophylaxis of attacks and
amyloid deposition in familial Mediterranean fever. However, because of many issues (eg …
amyloid deposition in familial Mediterranean fever. However, because of many issues (eg …
[HTML][HTML] Gout and hyperuricemia
MD Harris, LB Siegel, JA Alloway - American family physician, 1999 - aafp.org
Gout is a condition characterized by the deposition of monosodium urate crystals in the
joints or soft tissue. The four phases of gout include asymptomatic hyperuricemia, acute …
joints or soft tissue. The four phases of gout include asymptomatic hyperuricemia, acute …
Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease
Over the last decade, evidence has demonstrated that long-term, low-dose colchicine (0.5
mg daily) is effective for preventing gout flare and cardiovascular (CV) events in a wide …
mg daily) is effective for preventing gout flare and cardiovascular (CV) events in a wide …
[PDF][PDF] Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update
C Cerquaglia, M Diaco, G Nucera… - Current Drug Targets …, 2005 - researchgate.net
Pharmacological and Clinical Basis of Treatment of Familial Mediterranean Fever (FMF) with
Colchicine or Analogues: An Update Page 1 Current Drug Targets - Inflammation & Allergy …
Colchicine or Analogues: An Update Page 1 Current Drug Targets - Inflammation & Allergy …
Management of acute and chronic gouty arthritis: present state-of-the-art
N Schlesinger - Drugs, 2004 - Springer
There are three stages in the management of gout:(i) treating the acute attack;(ii) lowering
excess stores of uric acid to prevent flares of gouty arthritis and to prevent tissue deposition …
excess stores of uric acid to prevent flares of gouty arthritis and to prevent tissue deposition …
Colchicine: its mechanism of action and efficacy in crystal-induced inflammation
G Nuki - Current rheumatology reports, 2008 - Springer
New light has been shed on the mechanisms of action of colchicine in crystal-associated
arthropathies. Colchicine, long used to treat gout, arrests microtubule assembly and inhibits …
arthropathies. Colchicine, long used to treat gout, arrests microtubule assembly and inhibits …
Update on colchicine and its mechanism of action
Y Molad - Current rheumatology reports, 2002 - Springer
Colchicine is a unique anti-inflammatory drug with respect to its limited clinical usefulness
and its mode of action. Colchicine is mainly indicated for the treatment and prophylaxis of …
and its mode of action. Colchicine is mainly indicated for the treatment and prophylaxis of …